Comments to Shanghai People's Congress on the Regulations of Shanghai Pudong New Area on Promoting Zhangjiang Biomedical Industry Innovation (Draft)

2021-12-22 | Shanghai

Nearly 10 member companies commented on over 20 articles including:

- application and development of human cell & gene therapy

- human genetic resource management

- biological sample bank

- drug production licence application during clinical trial period

- registration service for drugs and medical equipment

- use of imported drugs and medical eqiupment

- customs clearance of R&D items

- bonded R&D and maintenance of medical equipment

- remanufacturing of medical equipment

- sharing of healthcare data 

- participation in expert committee

- government procurement support

- talent support

- financial and taxation support

- eco-environmental management